The latter activates NF-kB and the inflammasome nucleotide-binding domain, leucine-rich-containing family, and pyrin domain-containing-3 (NLRP3), resulting in the various degrees of hepatic inflammation observed in NASH/MASH patients [64]. Here, NFKB1 is linked to metabolic dysfunction-associated steatohepatitis.